Craig Polson

1.3k citations

17 papers · 595 indexed · h-index 11

Co-authors: Kevin M. Felsenstein David W. Smith Donna M. Barten Jason A. Corsa Valerie Guss D. John Faulkner Gene M. Dubowchik Owen B. Wallace
Topics: Alzheimer's disease research and treatments (10 papers)Computational Drug Discovery Methods (7 papers)Cholinesterase and Neurodegenerative Diseases (6 papers)
Cited by: Pharmacology Physiology Neurology
Journals: PLoS ONE Analytical Biochemistry Journal of Medicinal Chemistry
Partner nations: United States Germany

In The Last Decade

Craig Polson

17 papers receiving 580 citations

Peers

Countries citing papers authored by Craig Polson

Since Specialization

Citations

This map shows the geographic impact of Craig Polson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Polson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Polson more than expected).

Fields of papers citing papers by Craig Polson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Polson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Polson. The network helps show where Craig Polson may publish in the future.

Co-authorship network of co-authors of Craig Polson

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Polson. A scholar is included among the top collaborators of Craig Polson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Polson. Craig Polson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Stable isotope labeling by amino acids in cell culture-based liquid chromatography–mass spectrometry assay to measure microtubule dynamics in neuronal cell cultures 2014 ·Analytical Biochemistry ·Craig Polson,Joseph L. Cantone,Cong Wei,Dieter M. Drexler,Jere E. Meredith	2
2	Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease 2014 ·PLoS ONE ·Paul D. Wes,Amy Easton,John Corradi,Donna M. Barten,Nino Devidze,Lynn B. DeCarr,Amy Truong,Aiqing He,Nestor X. Barrezueta,Craig Polson,Clotilde Bourin,(unknown),(unknown),(unknown),Jere E. Meredith,JoAnne E. Natale,Sethu Sankaranarayanan,Greg Cadelina,(unknown),Angela Cacace	84
3	2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Michael F. Parker,Donna M. Barten,Carl P. Bergstrom,Joanne J. Bronson,Jason A. Corsa,Michael F. Dee,(unknown),Valerie Guss,(unknown),(unknown),Alice Loo,Robert Mate,(unknown),(unknown),Craig Polson,Susan B. Roberts,John E. Macor	2
4	P4‐020: Separation of Aβ Reduction from Notch Toxicity with Gamma Secretase Inhibitors in Rats 2010 ·Alzheimer s & Dementia ·Jere E. Meredith,Donna M. Barten,Catherine R. Burton,Jason A. Corsa,(unknown),Valerie Guss,Craig Polson,Dietmar Seiffert,Bruce D. Car,(unknown),Umesh Hanumegowda,Kimberley A. Lentz,Wendy Clarke,John E. Macor,Robert Zaczek,John G. Houston,Richard E. Olson,(unknown)	1
5	Amino-caprolactam derivatives as γ-secretase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Michael F. Parker,Joanne J. Bronson,Donna M. Barten,Jason A. Corsa,(unknown),Kevin M. Felsenstein,Valerie Guss,(unknown),Alice Loo,(unknown),(unknown),Ramesh Padmanabha,Roger H. Pak,Craig Polson,Jeremy H. Toyn,(unknown),Jian Wang,(unknown),Ming Zheng,Susan B. Roberts	10
6	Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer’s disease 2007 ·Bioorganic & Medicinal Chemistry Letters ·C. V. C. Prasad,Ming Zheng,(unknown),Carl P. Bergstrom,David W. Smith,Qi Gao,Suresh Yeola,Craig Polson,Jason A. Corsa,Valerie Guss,Alice Loo,Jian Wang,Bogdan Sleczka,Charles A. Dangler,Barbara Robertson,Joseph P. Hendrick,Susan B. Roberts,Donna M. Barten	21
7	Carbamate-appended N-alkylsulfonamides as inhibitors of γ-secretase 2007 ·Bioorganic & Medicinal Chemistry Letters ·Carl P. Bergstrom,C.P. Sloan,(unknown),David W. Smith,Ming Zheng,Steven Hansel,Craig Polson,Jason A. Corsa,Donna M. Barten,Kevin M. Felsenstein,Susan B. Roberts	9
8	Qualitative and quantitative characterization of the amyloid β peptide (Aβ) population in biological matrices using an immunoprecipitation–LC/MS assay 2007 ·Journal of Neuroscience Methods ·Michael J. Ford,Joseph L. Cantone,Craig Polson,Jeremy H. Toyn,Jere E. Meredith,Dieter M. Drexler	21
9	Nitrogen-appended N-alkylsulfonamides as inhibitors of γ-secretase 2007 ·Bioorganic & Medicinal Chemistry Letters ·Carl P. Bergstrom,C.P. Sloan,(unknown),Michael F. Parker,David W. Smith,Ming Zheng,Steven Hansel,Craig Polson,Lauren E. Barber,Isia Bursuker,Valerie Guss,Jason A. Corsa,Donna M. Barten,Kevin M. Felsenstein,Susan B. Roberts	9
10	In Vitro and In Vivo Metabolism of a Gamma-Secretase Inhibitor BMS-299897 and Generation of Active Metabolites in Milligram Quantities with a Microbial Bioreactor 2006 ·Current Drug Metabolism ·Donglu Zhang,Ronald L. Hanson,Vikram Roongta,Douglas D. Dischino,(unknown),C.P. Sloan,Craig Polson,(unknown),Ming Zheng,James Mitroka,Suzanne Wehrli,Suresh Yeola	4
11	Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Donna M. Barten,Valerie Guss,Jason A. Corsa,Alice Loo,Steven Hansel,Ming Zheng,(unknown),K. Srinivasan,Binghe Wang,Barbara Robertson,Craig Polson,Jue Wang,Susan B. Roberts,Joseph P. Hendrick,Jeffrey J. Anderson,James Loy,Ross M. Denton,Todd A. Verdoorn,David W. Smith,Kevin M. Felsenstein	118
12	Hydroxytriamides as potent γ-secretase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·C. V. C. Prasad,(unknown),C.P. Sloan,(unknown),(unknown),Michael F. Parker,David W. Smith,Steven Hansel,Craig Polson,Donna M. Barten,Kevin M. Felsenstein,Susan B. Roberts	19
13	2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase 2004 ·Bioorganic & Medicinal Chemistry Letters ·C. V. C. Prasad,(unknown),David W. Smith,Qi Gao,Craig Polson,Jason A. Corsa,Valerie Guss,Alice Loo,Donna M. Barten,Ming Zheng,Kevin M. Felsenstein,Susan B. Roberts	17
14	An Assessment of the Effects of Serotonin 6 (5-HT6) Receptor Antagonists in Rodent Models of Learning 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Mark D. Lindner,Donald B. Hodges,John B. Hogan,(unknown),Jason A. Corsa,Donna M. Barten,Craig Polson,Barbara Robertson,Valerie Guss,Kevin W. Gillman,John E. Starrett,Valentin K. Gribkoff	84
15	Inhibitors of Aβ production: solid-phase synthesis and SAR of α-hydroxycarbonyl derivatives 2003 ·Bioorganic & Medicinal Chemistry Letters ·Owen B. Wallace,David W. Smith,Milind Deshpande,Craig Polson,Kevin M. Felsenstein	70
16	Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition: Identification of (S)-N-[1-(4-Fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an Orally Bioavailable KCNQ2 Opener Devoid of CYP3A4 Metabolism-Dependent Inhibition 2003 ·Journal of Medicinal Chemistry ·Yong‐Jin Wu,Carl D. Davis,Steven I. Dworetzky,(unknown),David Harden,(unknown),Ronald J. Knox,Amy Newton,(unknown),Craig Polson,Digavalli V. Sivarao,Li‐Qiang Sun,Svetlana Tertyshnikova,David T. Weaver,Suresh Yeola,Mary Zoeckler,Michael Sinz	40
17	A new EGF-active polymeric pyridinium alkaloid from the sponge Callyspongia fibrosa 1993 ·The Journal of Organic Chemistry ·Michael T. Davies‐Coleman,D. John Faulkner,Gene M. Dubowchik,Gregory P. Roth,Craig Polson,C D Fairchild	84

About Craig Polson

Craig Polson is a scholar working on Computational Theory and Mathematics, Physiology and Pharmacology, having authored 17 papers that have together received 595 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (10 papers), Computational Drug Discovery Methods (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). The work is most often cited by research in Pharmacology (147 citations), Physiology (210 citations) and Neurology (64 citations). Craig Polson has collaborated with scholars based in United States and Germany. Frequent co-authors include Kevin M. Felsenstein, David W. Smith, Donna M. Barten, Jason A. Corsa, Valerie Guss, D. John Faulkner, Gene M. Dubowchik, Owen B. Wallace, Gregory P. Roth and Milind Deshpande. Their work appears in journals such as PLoS ONE, Analytical Biochemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact